ENTPD1 and neoplasm: Comparative analysis of PD-1, CD137, CD39 and CD103 as markers of reactive TIL demonstrated that expression of CD137 (4-1BB), a T cell activation marker, was the most selective and discriminating for the enrichment of tumor reactivity.